<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-biomedicines-08-00060">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hodi</surname>
    <given-names>F.S.</given-names>
   </name>
   <name>
    <surname>Oâ€™Day</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>McDermott</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>Weber</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Sosman</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Haanen</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Gonzalez</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Robert</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Schadendorf</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hassel</surname>
    <given-names>J.C.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Improved survival with ipilimumab in patients with metastatic melanoma</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2010</year>
  <volume>363</volume>
  <fpage>711</fpage>
  <lpage>723</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1003466</pub-id>
  <pub-id pub-id-type="pmid">20525992</pub-id>
 </element-citation>
</ref>
